Report Detail
Global Opioid Induced Constipation (OIC) Drugs Market Insights and Forecast to 2026
- RnM4149712 |
- 20 August, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Pharma & Healthcare
Opioid Induced Constipation (OIC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Opioid Induced Constipation (OIC) Drugs market is segmented into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Segment by Application, the Opioid Induced Constipation (OIC) Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Opioid Induced Constipation (OIC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Opioid Induced Constipation (OIC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Opioid Induced Constipation (OIC) Drugs Market Share Analysis
Opioid Induced Constipation (OIC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioid Induced Constipation (OIC) Drugs business, the date to enter into the Opioid Induced Constipation (OIC) Drugs market, Opioid Induced Constipation (OIC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1 Study Coverage
- 1.1 Opioid Induced Constipation (OIC) Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Opioid Induced Constipation (OIC) Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Type
- 1.4.2 Lubiprostone
- 1.4.3 Methyl Naltrexone Bromide
- 1.4.4 Naldemedine
- 1.4.5 Alvimopan
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2015-2026
- 2.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2015-2026
- 2.2 Global Opioid Induced Constipation (OIC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioid Induced Constipation (OIC) Drugs Competitor Landscape by Players
- 3.1 Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers
- 3.1.1 Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers
- 3.2.1 Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drugs Revenue in 2019
- 3.2.5 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Opioid Induced Constipation (OIC) Drugs Price by Manufacturers
- 3.4 Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Opioid Induced Constipation (OIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2015-2020)
- 4.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2015-2020)
- 4.1.3 Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Opioid Induced Constipation (OIC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2015-2020)
- 5.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2015-2020)
- 5.1.3 Opioid Induced Constipation (OIC) Drugs Price by Application (2015-2020)
- 5.2 Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Opioid Induced Constipation (OIC) Drugs by Country
- 6.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Country
- 6.1.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Type
- 6.3 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Opioid Induced Constipation (OIC) Drugs by Country
- 7.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country
- 7.1.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Type
- 7.3 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs by Region
- 8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region
- 8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Opioid Induced Constipation (OIC) Drugs by Country
- 9.1.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country
- 9.1.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Type
- 9.3 Central & South America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by Country
- 10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country
- 10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Ironwood Pharmaceuticals Inc
- 11.1.1 Ironwood Pharmaceuticals Inc Corporation Information
- 11.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
- 11.1.3 Ironwood Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.1.5 Ironwood Pharmaceuticals Inc Related Developments
- 11.2 Daiichi Sankyo Co Ltd
- 11.2.1 Daiichi Sankyo Co Ltd Corporation Information
- 11.2.2 Daiichi Sankyo Co Ltd Description and Business Overview
- 11.2.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.2.5 Daiichi Sankyo Co Ltd Related Developments
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description and Business Overview
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.3.5 Pfizer Related Developments
- 11.4 Progenics Pharmaceuticals Inc
- 11.4.1 Progenics Pharmaceuticals Inc Corporation Information
- 11.4.2 Progenics Pharmaceuticals Inc Description and Business Overview
- 11.4.3 Progenics Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.4.5 Progenics Pharmaceuticals Inc Related Developments
- 11.5 Shionogi & Co., Ltd
- 11.5.1 Shionogi & Co., Ltd Corporation Information
- 11.5.2 Shionogi & Co., Ltd Description and Business Overview
- 11.5.3 Shionogi & Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.5.5 Shionogi & Co., Ltd Related Developments
- 11.6 Allergan Plc
- 11.6.1 Allergan Plc Corporation Information
- 11.6.2 Allergan Plc Description and Business Overview
- 11.6.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.6.5 Allergan Plc Related Developments
- 11.7 Nektar Therapeutics
- 11.7.1 Nektar Therapeutics Corporation Information
- 11.7.2 Nektar Therapeutics Description and Business Overview
- 11.7.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.7.5 Nektar Therapeutics Related Developments
- 11.8 Purdue Pharma
- 11.8.1 Purdue Pharma Corporation Information
- 11.8.2 Purdue Pharma Description and Business Overview
- 11.8.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.8.5 Purdue Pharma Related Developments
- 11.9 S.L.A. Pharma AG
- 11.9.1 S.L.A. Pharma AG Corporation Information
- 11.9.2 S.L.A. Pharma AG Description and Business Overview
- 11.9.3 S.L.A. Pharma AG Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.9.5 S.L.A. Pharma AG Related Developments
- 11.10 Mundipharma International Limited
- 11.10.1 Mundipharma International Limited Corporation Information
- 11.10.2 Mundipharma International Limited Description and Business Overview
- 11.10.3 Mundipharma International Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.10.5 Mundipharma International Limited Related Developments
- 11.1 Ironwood Pharmaceuticals Inc
- 11.1.1 Ironwood Pharmaceuticals Inc Corporation Information
- 11.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
- 11.1.3 Ironwood Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
- 11.1.5 Ironwood Pharmaceuticals Inc Related Developments
- 11.12 Takeda Pharmaceutical Company Limited
- 11.12.1 Takeda Pharmaceutical Company Limited Corporation Information
- 11.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
- 11.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Takeda Pharmaceutical Company Limited Products Offered
- 11.12.5 Takeda Pharmaceutical Company Limited Related Developments
- 11.13 Theravance Biopharma Inc
- 11.13.1 Theravance Biopharma Inc Corporation Information
- 11.13.2 Theravance Biopharma Inc Description and Business Overview
- 11.13.3 Theravance Biopharma Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Theravance Biopharma Inc Products Offered
- 11.13.5 Theravance Biopharma Inc Related Developments
- 11.14 Bausch Health
- 11.14.1 Bausch Health Corporation Information
- 11.14.2 Bausch Health Description and Business Overview
- 11.14.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Bausch Health Products Offered
- 11.14.5 Bausch Health Related Developments
- 11.15 Cosmo Pharmaceuticals SA
- 11.15.1 Cosmo Pharmaceuticals SA Corporation Information
- 11.15.2 Cosmo Pharmaceuticals SA Description and Business Overview
- 11.15.3 Cosmo Pharmaceuticals SA Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Cosmo Pharmaceuticals SA Products Offered
- 11.15.5 Cosmo Pharmaceuticals SA Related Developments
- 11.16 Daewoong Pharmaceutical
- 11.16.1 Daewoong Pharmaceutical Corporation Information
- 11.16.2 Daewoong Pharmaceutical Description and Business Overview
- 11.16.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Daewoong Pharmaceutical Products Offered
- 11.16.5 Daewoong Pharmaceutical Related Developments
- 11.17 C.B. Fleet Company
- 11.17.1 C.B. Fleet Company Corporation Information
- 11.17.2 C.B. Fleet Company Description and Business Overview
- 11.17.3 C.B. Fleet Company Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 C.B. Fleet Company Products Offered
- 11.17.5 C.B. Fleet Company Related Developments
- 11.18 Sucampo Pharmaceuticals
- 11.18.1 Sucampo Pharmaceuticals Corporation Information
- 11.18.2 Sucampo Pharmaceuticals Description and Business Overview
- 11.18.3 Sucampo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Sucampo Pharmaceuticals Products Offered
- 11.18.5 Sucampo Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Region
- 12.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Opioid Induced Constipation (OIC) Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Opioid Induced Constipation (OIC) Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Opioid Induced Constipation (OIC) Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Opioid Induced Constipation (OIC) Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Opioid Induced Constipation (OIC) Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Opioid Induced Constipation (OIC) Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Opioid Induced Constipation (OIC) Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Opioid Induced Constipation (OIC) Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Opioid Induced Constipation (OIC) Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Opioid Induced Constipation (OIC) Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Opioid Induced Constipation (OIC) Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Opioid Induced Constipation (OIC) Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Opioid Induced Constipation (OIC) Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Opioid Induced Constipation (OIC) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Opioid Induced Constipation (OIC) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Opioid Induced Constipation (OIC) Drugs. Industry analysis & Market Report on Opioid Induced Constipation (OIC) Drugs is a syndicated market report, published as Global Opioid Induced Constipation (OIC) Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Opioid Induced Constipation (OIC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
